Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness.

Nimalan Arinaminpathy Arindam NandiShibu VijayanNita JhaSreenivas A NairSameer KumtaPuneet DewanKiran RadeBhavin VaderaRaghuram RaoKuldeep S Sachdeva

Published in: BMJ global health (2021)

To accelerate decline in TB incidence, it is critical first to engage effectively with the private sector in India. Mechanisms such as the PPIA offer cost-effective ways of doing so, particularly when tailored to local settings.

Keyphrases

healthcare
mycobacterium tuberculosis
health insurance
risk factors
pulmonary tuberculosis
hiv aids
smoking cessation
human immunodeficiency virus
antiretroviral therapy
hiv infected